Home Family Medicine Consulting Skills

Consulting Skills

📋 Key Information Summary

📋
  • The GP consultation is the central unit of general-practice care; a structured approach improves diagnostic accuracy, patient satisfaction, and health outcomes.
  • Major consultation models include the Calgary–Cambridge framework, Pendleton's rules, the Patient-Centred Clinical Method (Stewart & Brown), and the Bio-Psychosocial model (Engel).
  • The Calgary–Cambridge model divides the consultation into five stages: initiating the session, gathering information, physical examination, explanation & planning, and closing the session.
  • Effective history-taking relies on a balance of open-ended questioning, focused clarification, and active listening; the "golden minute" of silence after an opening question yields the patient's true agenda.
  • Patient-centred interviewing techniques — including motivational interviewing, the BATHE technique, and the ask–tell–ask method — support shared decision-making and behaviour change.
  • The physical and mental-state examination in general practice should be guided by clinical suspicion from the history; targeted examination is often more efficient than a comprehensive screen.
  • The Mental State Examination (MSE) encompasses appearance, behaviour, speech, mood, affect, thought content, thought form, perception, cognition, insight, and judgement.
  • The management phase integrates explanation, shared decision-making, prescribing, safety-netting, referral, and follow-up planning.
  • Australian Medicare Benefits Schedule (MBS) item numbers distinguish standard consultations (Level A–D) from longer consultations, chronic disease management plans (721, 723), and health assessments (701, 703, 705, 707, 715).
  • Cultural safety — particularly for Aboriginal and Torres Strait Islander Australians — requires understanding of historical context, yarning as a communication framework, and the use of culturally appropriate health resources.
  • Medico-legal documentation should be contemporaneous, legible, dated, timed, and include the clinician's name, designation, and relevant clinical reasoning.
  • Time management within the standard 15-minute appointment requires agenda-setting, prioritisation of presenting problems, and clear safety-netting for undifferentiated symptoms.

Introduction & Australian Context

The general-practice consultation is the cornerstone of primary healthcare in Australia. Australians make approximately 160 million GP visits annually, with an average of 6.2 consultations per person per year (AIHW 2023). The quality of the consultation directly influences diagnostic accuracy, patient adherence, health outcomes, and medicolegal risk.

Consulting skills are not innate — they are learnable, practisable, and assessable competencies. The Royal Australian College of General Practitioners (RACGP) mandates consulting skills as a core component of fellowship training across all five domains of the RACGP curriculum. Competency in consulting skills encompasses communication, clinical reasoning, physical examination, shared decision-making, and cultural safety.

A structured approach to the GP consultation — incorporating models of the consultation, systematic history-taking, targeted examination, and evidence-based management — provides a reliable scaffold that protects both the patient and the clinician. This article outlines the key phases and techniques that underpin effective consulting in Australian general practice.

📊
Australian GP consultation data: In 2022–23, there were 163.7 million Medicare-subsidised GP attendances in Australia. The median consultation length is 15 minutes (Level B), yet 25% of consultations involve 3+ problems. Structured consulting skills are essential for managing complexity within time constraints (AIHW, Medicare Statistics 2023).

Models of the Consultation

Consultation models provide conceptual frameworks that guide the clinician through the structure and process of the medical encounter. No single model is universally superior; experienced GPs often blend elements from multiple models depending on the clinical context.

The Calgary–Cambridge Framework

Developed by Kurtz, Silverman, and Draper (1998, updated 2005), the Calgary–Cambridge model is the most widely taught consultation framework in Australian GP training. It provides a skills-based approach with five clearly delineated stages:

1
Initiating the Session
Preparation, greeting, establishing rapport, identifying the reason for attendance, and setting the agenda.
2
Gathering Information
Exploration of the patient's problem using both disease-focused and patient-centred questioning; understanding the patient's ideas, concerns, and expectations (ICE).
3
Physical Examination
Focused, hypothesis-driven examination integrated with the history; informed consent, patient dignity, and explanation of findings.
4
Explanation & Planning
Sharing information at the patient's level of understanding, exploring management options, negotiating a shared plan, and incorporating shared decision-making.
5
Closing the Session
Summarising the agreed plan, safety-netting, organising follow-up, and ensuring the patient has no further concerns.

Pendleton's Rules (1984)

David Pendleton's feedback model focuses on what went well and what could be improved, and is widely used in GP registrar supervision and clinical teaching. The seven tasks of the consultation are:

  • Define the reason for the patient's attendance (including symptoms, ideas, expectations, and the effects of the problem).
  • Consider other problems (including continuing problems).
  • Choose an appropriate action for each problem.
  • Achieve a shared understanding of the problems and their management.
  • Involve the patient in the management plan and encourage self-management.
  • Use time and resources efficiently.
  • Establish and maintain an appropriate doctor–patient relationship.

Patient-Centred Clinical Method (Stewart & Brown)

Stewart, Brown, Weston, McWhinney, McWilliam, and Freeman's Patient-Centred Clinical Method (5th edition, 2014) identifies six interactive components:

  • Exploring both the disease and the illness experience.
  • Understanding the whole person (contextual factors including family, work, culture).
  • Finding common ground (shared understanding of the problem and goals of treatment).
  • Incorporating prevention and health promotion.
  • Enhancing the doctor–patient relationship.
  • Being realistic about time, resources, and limitations.

The Bio-Psychosocial Model (Engel, 1977)

George Engel's bio-psychychosocial model expanded the biomedical model to include psychological and social determinants of health. In Australian general practice, this is particularly relevant given the burden of mental health presentations (approximately 1 in 7 GP encounters involve a mental health component — BEACH study data, Britt et al.), the impact of social determinants of health on Indigenous communities, and the increasing recognition of chronic disease management as a bio-psychosocial endeavour.

Balint's Approach (1957)

Michael Balint's work on "The Doctor, His Patient and the Illness" introduced the concept of the doctor as a therapeutic instrument. Balint groups (small-group reflective practice) remain a component of GP training in Australia and focus on the unconscious dynamics of the doctor–patient relationship, including "collusion of anonymity" in patients with medically unexplained symptoms.

Model Key Focus Best Suited For
Calgary–Cambridge Skills-based structure with observable behaviours Teaching, assessment, OSCE preparation
Pendleton's Rules Feedback and consultation review Supervision, registrar teaching
Patient-Centred Clinical Method Understanding the whole person Complex care, chronic disease, mental health
Bio-Psychosocial Beyond the biomedical model Functional symptoms, social determinants
Balint Doctor–patient relationship dynamics Reflective practice, difficult consultations

The History & Interviewing Techniques

The history remains the most powerful diagnostic tool in general practice. Studies consistently demonstrate that 70–80% of diagnoses can be made from the history alone (Hampton et al., 1975; Peterson et al., 1992). In the Australian GP context, where consultations are time-limited (typically 15–20 minutes), efficient and skilled interviewing is paramount.

Structure of the Medical History

Component Key Elements Tips for Australian GP Practice
Presenting complaint Patient's own words; open-ended exploration Allow the "golden minute" — do not interrupt within the first 60 seconds (Beckman & Frankel, 1984)
History of presenting complaint (HPC) Onset, site, radiation, character, associations, timing, exacerbating/relieving factors, severity (SOCRATES mnemonic) Use SOCRATES for pain; adapt mnemonics to the presenting problem
Ideas, Concerns, Expectations (ICE) "What do you think is going on?" "What worries you most?" "What were you hoping we could do today?" ICE exploration is a mandated competency in RACGP training; essential for shared decision-making
Past medical & surgical history Previous diagnoses, hospitalisations, operations, complications Review My Health Record (if consented) and practice software (e.g., Best Practice, Medical Director)
Medications & allergies Current medications (including OTC, complementary), drug allergies and intolerances Cross-check with PBS claims history; reconcile after hospital discharge
Family history First-degree relatives; relevant hereditary conditions Important for cardiovascular, cancer, and genetic risk assessment
Social history Occupation, living situation, smoking, alcohol, drugs, exercise, travel Use AUDIT-C or ASSIST screening tools; document ATSI status respectfully
Review of systems Targeted questioning based on differential diagnosis Avoid exhaustive ROS unless performing a health assessment (MBS 701–715)

Core Interviewing Techniques

  • Open-ended questions: Begin each new topic with an open question (e.g., "Tell me more about the chest pain"). This maximises information yield and respects the patient's narrative.
  • Focused/clarifying questions: Progressively narrow the differential using specific, closed questions (e.g., "Is the pain worse on exertion?").
  • Reflective listening: Mirror the patient's language and emotion (e.g., "It sounds like that was really frightening for you"). Builds rapport and validates the patient's experience.
  • Facilitation: Non-verbal cues (nodding, eye contact) and verbal cues ("Go on…", "Uh-huh") encourage the patient to continue their narrative.
  • Signposting: Orient the patient to transitions in the consultation (e.g., "I'd now like to ask you a few more specific questions about the headache, if that's OK").
  • Empathy statements: Explicitly acknowledge the patient's feelings (e.g., "I can see how worried you are about this").

Motivational Interviewing (MI)

Motivational interviewing (Miller & Rollnick, 3rd edition, 2013) is an evidence-based, patient-centred communication style designed to strengthen personal motivation for change. It is particularly relevant in Australian general practice for smoking cessation, alcohol reduction, weight management, medication adherence, and chronic disease self-management.

  • Spirit of MI: Partnership, acceptance, compassion, evocation.
  • Core skills (OARS): Open questions, Affirmations, Reflective listening, Summarising.
  • Processes: Engaging → Focusing → Evoking → Planning.
💡
BATHE Technique (Stuart & Lieberman): A rapid psychosocial assessment tool ideal for time-limited consultations: Background ("What is going on in your life?"), Affect ("How do you feel about that?"), THandling ("How are you handling it?"), Empathy ("That must be very difficult"). Takes under 2 minutes and provides powerful psychosocial insight.

Ask–Tell–Ask Method

An information-sharing technique used in the explanation and planning phase:

  • Ask: "What do you already know about [condition]?" (assess baseline understanding).
  • Tell: Provide targeted information at the patient's level of comprehension (chunk and check).
  • Ask: "Does that make sense? What questions do you have?" (confirm understanding).

Working with Interpreters in Australian General Practice

Approximately 21% of Australians speak a language other than English at home (ABS Census 2021). Best practice for interpreter use includes:

  • Use professional interpreters (TIS National — Translating and Interpreting Service, funded by the Department of Home Affairs) rather than family members, especially for sensitive topics.
  • Speak directly to the patient in the first person (e.g., "Where does it hurt?" not "Ask her where it hurts").
  • Allow additional consultation time (MBS Level C or D consultation items for longer consultations).
  • For Aboriginal and Torres Strait Islander patients in remote communities, use Aboriginal Health Workers or community interpreters where available.

Physical & Mental Examination

Physical examination in general practice differs from hospital-based examination in several important ways: it is typically hypothesis-driven (guided by the history), performed within time constraints, and conducted in a consulting room with limited equipment. The RACGP curriculum requires competency in a comprehensive range of examination skills, but clinical efficiency demands targeted, focused examination in most consultations.

Principles of Physical Examination in General Practice

  • Informed consent: Explain what you intend to do and why; obtain verbal consent. For intimate examinations (breast, rectal, genital), written consent may be appropriate and a chaperone should be offered (RACGP Position Statement on Chaperones, 2020).
  • Exposure and dignity: Expose only the area being examined; use draping; maintain a warm environment.
  • Inspection first: Observe before touching. Up to 80% of clinical signs can be detected by careful inspection.
  • Compare sides: Where applicable (e.g., neurological examination, joint examination), always compare with the unaffected side.
  • Narrate your findings: Explain what you are doing and what you find, in language the patient can understand.

Essential Equipment for the GP Consulting Room

Equipment Common Uses in General Practice
Sphygmomanometer (automated preferred; mercury if calibrated) Cardiovascular risk assessment, hypertension management
Stethoscope Cardiac, respiratory, and abdominal auscultation
Otoscope / ophthalmoscope ENT and eye examinations
Thermometer (tympanic or temporal) Fever assessment
Pulse oximeter Respiratory assessment, COPD, COVID-19 monitoring
Glucometer / point-of-care testing Diabetes monitoring; available under MBS for practices with QICC/QICGP accreditation
Peak flow meter Asthma and COPD assessment
Snellen chart (or electronic equivalent) Visual acuity assessment
Reflex hammer, tuning fork (128 Hz), monofilament (10 g) Neurological and diabetic foot examination
ECG machine (if available) or access to pathology collection Chest pain, palpitations, preoperative assessment

The Mental State Examination (MSE)

The MSE is a structured assessment of a patient's current psychiatric state. It is analogous to the physical examination for mental health presentations and is essential for mental health care plans (MBS items 721, 723) and risk assessment. The MSE should be systematically documented across the following domains:

Domain Assessment Questions Example Documentation
Appearance Grooming, dress, age-appropriate, nutrition, psychomotor activity "Well-groomed 45-year-old male, appropriately dressed, BMI 32"
Behaviour Cooperative, eye contact, rapport, psychomotor agitation/retardation "Cooperative, reduced eye contact, psychomotor retardation noted"
Speech Rate, volume, tone, spontaneity, coherence "Slow rate, low volume, monosyllabic responses"
Mood Patient's self-reported emotional state "Patient describes mood as 'terrible, I can't go on'"
Affect Observed emotional expression: range, reactivity, congruence, appropriateness "Flat affect, restricted range, congruent with depressed mood"
Thought content Delusions, obsessions, suicidal/homicidal ideation, preoccupations "Denies current suicidal ideation; persistent worry about financial ruin"
Thought form Logical, tangential, loosening of associations, flight of ideas, thought blocking "Linear and goal-directed; no formal thought disorder"
Perception Hallucinations (auditory, visual, tactile), illusions, derealisation "No hallucinations reported or observed"
Cognition Orientation (person, place, time), attention, memory (short- and long-term), executive function "Oriented ×3; MMSE 24/30; difficulty with serial 7s and recall"
Insight Awareness of illness, understanding of need for treatment "Partial insight; acknowledges low mood but attributes it to external stressors only"
Judgement Ability to make reasonable decisions; risk to self/others "Judgement impaired; agreed to safety plan and crisis contact numbers"
⚠️
Suicide risk assessment: If a patient discloses suicidal ideation during the consultation, conduct a structured risk assessment. Useful tools include the Columbia-Suicide Severity Rating Scale (C-SSRS). Always document risk and safety plan. In an emergency, contact 000 or your state's Acute Mental Health Crisis line. For ongoing support: Lifeline 13 11 14, Beyond Blue 1300 22 4636, 13YARN (for Aboriginal and Torres Strait Islander peoples) 13 92 76.

Cognitive Assessment Tools in General Practice

  • MMSE (Mini-Mental State Examination): 30-point screening tool; score <24 suggests cognitive impairment. Takes approximately 10 minutes. (Not freely available — requires purchasing a licence.)
  • GPCOG (General Practitioner Assessment of Cognition): Validated, free, designed specifically for Australian general practice. Takes 4–5 minutes. Includes an informant component.
  • MoCA (Montreal Cognitive Assessment): More sensitive than MMSE for mild cognitive impairment (MCI). Score <26 suggests impairment. Free for clinical use.
  • 7-Minute Screen / TYM (Test Your Memory): Alternative tools with varying sensitivities.

Focused Examination by System

The following table summarises key examination approaches for common presentations in Australian general practice:

Presentation Key Examination Components Red Flags
Chest pain Vitals, cardiovascular (murmurs, JVP, peripheral oedema), respiratory, chest wall tenderness, BMI Hypotension, new murmur, unilateral reduced breath sounds, diaphoresis
Headache Neurological (cranial nerves, fundoscopy, visual fields, motor/sensory, coordination), temporal artery tenderness, meningism Papilloedema, focal neurological deficit, neck stiffness, temporal artery thickening
Abdominal pain Inspection, auscultation, light palpation (peritonism), deep palpation, Murphy's sign, Rovsing's sign, hernial orifices, DRE if indicated Guarding, rigidity, rebound tenderness, absent bowel sounds
Shortness of breath Vitals (SpO₂ essential), respiratory (wheeze, crackles, reduced air entry), cardiovascular (JVP, peripheral oedema), chest expansion SpO₂ <92%, silent chest, tracheal deviation, tension pneumothorax signs
Knee pain Inspection (alignment, effusion, erythema), range of movement, ligament stability (ACL/PCL, MCL/LCL), meniscal tests (McMurray's), patellar assessment Locked knee, large tense effusion, inability to weight-bear
Depression / anxiety Full MSE (as above), PHQ-9, GAD-7 screening, suicide risk assessment, functional impairment assessment Active suicidal ideation with plan/intent, psychotic features, severe functional impairment

Management Phase of the Consultation

The management phase encompasses explanation of findings, shared decision-making, prescribing (where indicated), safety-netting, referral, and follow-up planning. This phase closes the loop of the consultation and directly influences patient outcomes and adherence.

Explanation & Shared Decision-Making

  • Use plain language: Avoid jargon. Check understanding using the "teach-back" method ("Can you explain back to me what we've discussed today?").
  • Provide written information: Use reputable patient resources such as healthdirect.gov.au, RACGP patient handouts, or condition-specific fact sheets.
  • Shared decision-making: Present options (including watchful waiting), discuss benefits, risks, and alternatives, and elicit the patient's preferences. The Ottawa Decision Support Framework is a useful tool for preference-sensitive decisions.
  • Decision aids: For common preference-sensitive decisions (e.g., prostate cancer screening, knee osteoarthritis management, antidepressant initiation), patient decision aids can improve knowledge and reduce decisional conflict (NHMRC-endorsed).

Prescribing Principles in Australian General Practice

  • Prescribe generic medications where possible (PBS policy); note brand names where patients are established on a specific brand.
  • Check for drug interactions (use the AMH Drugs app or MIMS Online).
  • Consider PBS restrictions and authority requirements (Services Australia PBS Online).
  • Use real-time prescription monitoring (SafeScript VIC, ScriptCheck NSW, QScript QLD, NT Check, etc.) for Schedule 8 medicines and high-risk Schedule 4 drugs.
  • Discuss potential side effects and expected duration of treatment.
  • Address antibiotic stewardship: do not prescribe antibiotics for viral upper respiratory infections; use the NPS MedicineWise "Choosing Wisely" recommendations.

Safety-Netting

Safety-netting is a critical risk-management strategy in general practice, especially for undifferentiated symptoms and conditions with diagnostic uncertainty. Effective safety-netting involves three components:

  • Information: Tell the patient what to watch for (specific red-flag symptoms).
  • Time frame: Provide a clear time frame for expected improvement (e.g., "If the cough has not improved in 3 weeks, come back").
  • Action: Specify what to do if symptoms worsen (e.g., "If you develop fever or difficulty breathing, go to your nearest emergency department or call 000").
🚨
Document safety-netting advice. Failure to safety-net and document the advice is a common finding in medicolegal cases involving missed diagnoses. Always record the specific advice given, the time frame, and the planned follow-up in the clinical notes.

Referral

Referral is appropriate when a diagnosis is uncertain, specialist treatment is required, or the patient's needs exceed the scope of general practice. In Australia:

  • GP referral letter: Should include presenting complaint, relevant history, examination findings, investigations performed, provisional diagnosis, reason for referral, and urgency.
  • Urgency categorisation: Use the urgency grading system required by the receiving service (Category 1 — emergency, Category 2 — urgent, Category 3 — routine, Category 4 — information). Public hospital outpatient wait times are often 12+ months for Category 3 (AIHW data).
  • MBS referral items: Specialist attendance requires a valid GP referral (MBS items 99, 104, 105, 110, etc.). Chronic disease management plans (MBS 721, 723) and team care arrangements facilitate access to allied health (up to 5 services per calendar year).
  • My Health Record: Upload shared health summaries and event summaries to facilitate continuity of care during referrals (with patient consent).

Follow-Up & Continuity of Care

  • Arrange follow-up based on clinical need — sooner for acute/emerging problems, regular intervals for chronic disease management.
  • Use recall systems (automated in most Australian practice software) for chronic disease monitoring (HbA1c, BP, cervical screening, etc.).
  • Document the follow-up plan clearly, including who is responsible for each component of care (GP, specialist, allied health, patient).
  • Ensure the patient knows how to contact the practice for urgent concerns between appointments.

Documentation & Medico-Legal Requirements

Good documentation protects the patient and the clinician. The RACGP recommends the following standards:

  • Contemporaneous (recorded at the time of or immediately after the consultation).
  • Legible and attributable (include date, time, clinician's name and designation).
  • Include clinical reasoning — not just findings, but why decisions were made.
  • Document any refusal of recommended treatment or deviation from guidelines, including the patient's reasons and that risks were explained.
  • Comply with the Australian Privacy Principles (Privacy Act 1988) and state-based health records legislation.

MBS Billing for GP Consultations

MBS Item Description Typical Duration
3 (Level A) Brief attendance — straightforward, <5 min <5 min
23 (Level B) Standard attendance — most common GP item 6–20 min
36 (Level C) Long attendance — complex presentations 20–40 min
44 (Level D) Prolonged attendance — very complex >40 min
721 GP Management Plan (GPMP) for chronic disease ≥15 min (separate appointment recommended)
723 Team Care Arrangement (TCA) ≥15 min
701 / 703 / 705 / 707 Health assessments (45–75 age, Aboriginal and Torres Strait Islander, refugees) ≥30 min
715 Aboriginal and Torres Strait Islander health assessment ≥30 min; available once per 9 months for all ages

Special Populations & Contexts

👶

Paediatric Consultations

Develop rapport with the child first — get down to their level, use age-appropriate language, and involve play or drawing for younger children.
The parent is both historian and interpreter of the child's symptoms; validate parental concerns (especially first-time parents).
Observe the child's behaviour, interaction with the parent, and general appearance before commencing formal examination.
Use validated paediatric screening tools: Edinburgh Postnatal Depression Scale (EPDS) for parents, ASQ-3 for developmental screening, HEEADSSS for adolescent psychosocial assessment.
Weight management: use BMI-for-age percentile charts (WHO growth charts adapted for Australian children).
👴

Elderly Patients

Allow additional time — hearing impairment, cognitive impairment, polypharmacy, and multiple comorbidities all extend the consultation.
Screen for geriatric syndromes: falls risk (Timed Up and Go test), polypharmacy (use the Beers Criteria or STOPP/START criteria), cognitive decline (GPCOG/MoCA), incontinence, frailty (Clinical Frailty Scale).
Address advance care planning (ACP) — the RACGP recommends initiating ACP discussions proactively in patients with chronic or life-limiting conditions.
Consider home visit MBS items (item numbers 5000–5067) for housebound patients.
Review medications regularly — deprescribing is a key part of managing polypharmacy in the elderly.
🤰

Pregnant Patients

Shared antenatal care with a birthing facility — the GP's role includes routine antenatal checks, screening, education, and psychosocial support.
Antenatal screening schedule: first visit (dating scan, bloods — FBC, blood group, antibodies, rubella, hep B, hep C, HIV, syphilis, chlamydia; MSU; ATSI screening — STIs, trachoma); 28-week GTT, anti-D if Rh-negative; 36-week GBS swab.
Medication safety: use the Australian categorisation system for prescribing in pregnancy (A, B1, B2, B3, C, D, X). Refer to the TGA pregnancy categories.
Perinatal mental health screening: EPDS at booking visit and again at 6–12 weeks postnatal; refer if score ≥13 or positive for question 10 (self-harm thoughts).
🫘

Patients with Renal Impairment

Calculate eGFR for all patients with risk factors (diabetes, hypertension, family history, ATSI background, age >60).
Adjust medication doses according to renal function — reference the Australian Medicines Handbook (AMH) renal dosing tables.
Avoid or dose-adjust NSAIDs, metformin (if eGFR <30), lithium, methotrexate, and gadolinium-based contrast (if eGFR <30) in significant renal impairment.
Coordinate care with nephrology when eGFR declines to <30 mL/min/1.73 m² or proteinuria is significant (ACR >30 mg/mmol).
🫁

Patients with Hepatic Impairment

Dose-adjust hepatically cleared drugs using the Child-Pugh classification (A = mild, B = moderate, C = severe).
Avoid paracetamol >2 g/day in chronic liver disease; avoid NSAIDs in cirrhosis.
Screen for hepatocellular carcinoma (6-monthly ultrasound) in patients with cirrhosis (any aetiology).
Consider hepatitis B and C screening in at-risk populations (ATSI, IVDU, migrant communities from endemic areas).
🛡️

Immunocompromised Patients

Ensure pneumococcal vaccination (23vPPV every 5 years; 13vPCV if not previously received), annual influenza, and COVID-19 boosters as per ATAGI recommendations.
Have a low threshold for investigation and empirical treatment of infections — consider broader differentials and atypical organisms.
For patients on immunosuppressive therapy (biologics, DMARDs, corticosteroids), coordinate with the prescribing specialist regarding infection risk and vaccination timing.
Screen for latent tuberculosis before commencing immunosuppression (Mantoux or IGRA).

Aboriginal and Torres Strait Islander Health

Aboriginal and Torres Strait Islander Health Considerations

Effective consulting with Aboriginal and Torres Strait Islander Australians requires cultural safety, an understanding of historical and ongoing impacts of colonisation, and the use of culturally appropriate communication frameworks. The health gap between Indigenous and non-Indigenous Australians (life expectancy gap of approximately 8 years for males and 8.6 years for females — AIHW 2023) is driven by social determinants of health, barriers to accessing healthcare, and historical distrust of mainstream health services.

Cultural Safety in the Consultation

  • Acknowledge Country: Recognise the Traditional Owners of the land on which the practice is located. Many practices display a formal Acknowledgement of Country.
  • Ask, don't assume: "Would you like to tell me about your mob and where your family is from?" is more respectful than assuming identity or making assumptions based on appearance.
  • Use of the term "Aboriginal and Torres Strait Islander": This is the respectful, inclusive term. Avoid "Aboriginal" alone (which excludes Torres Strait Islanders) or outdated terms.
  • Yarning: Yarning is a culturally grounded communication style characterised by storytelling, circular rather than linear narrative, and relationship-building. Incorporating yarning into the consultation — especially during the rapport-building and history-taking phases — can significantly improve patient engagement and information disclosure.
  • Silent pauses: Extended silence is comfortable and valued in many Aboriginal and Torres Strait Islander communication styles. Do not rush to fill silences.

Barriers to Healthcare Access

Geographical remoteness
Approximately 45% of Aboriginal and Torres Strait Islander people live in regional or remote areas with limited access to GP services. Telehealth (MBS items 91790, 91800, 91801, 91802) has expanded access since COVID-19 but digital connectivity remains a barrier.
Cost
Despite bulk-billing incentives (MBS bulk-billing incentive items 10990 and 10991 for concessional patients), out-of-pocket costs for medications, allied health, and specialist care remain significant barriers. Close the Gap PBS co-payment is available for Indigenous Australians with or without a concession card.
Cultural safety of services
Aboriginal Community Controlled Health Organisations (ACCHOs, e.g., AMSs — Aboriginal Medical Services) provide culturally safe primary healthcare. Where ACCHOs are not available, mainstream practices should ensure cultural safety training for all staff, presence of Aboriginal Health Workers/Practitioners, and welcoming physical environments.
Historical distrust
The legacy of the Stolen Generations, forced removal of children, and institutional racism has created deep-seated distrust of government-funded services. Building trust takes time and consistency. Avoid defensiveness; listen with humility.
Communication and health literacy
English may be a second, third, or fourth language for some Aboriginal and Torres Strait Islander patients, particularly in remote communities. Use plain English, visual aids, and Aboriginal Health Workers or interpreters (Aboriginal Interpreter Service — available in NT, WA, QLD). The "teach-back" method is particularly important.

The Aboriginal and Torres Strait Islander Health Assessment (MBS 715)

MBS item 715 provides a comprehensive annual health assessment for Aboriginal and Torres Strait Islander people of any age. It is available once per 9-month period and is a critical entry point for preventive healthcare and chronic disease management. Key components include:

  • Physical examination (including eyes, ears, cardiovascular, respiratory, musculoskeletal, skin).
  • Screening for chronic disease risk factors (smoking, alcohol, nutrition, physical activity, obesity).
  • Pathological investigations (FBC, EUC, LFTs, lipids, HbA1c, urine ACR, STI screening, hepatitis B serology where indicated).
  • Immunisation status review.
  • Social and emotional wellbeing assessment (use the SEWB tool or the Kessler-5/K10 for psychological distress screening).
  • Follow-up plan with appropriate referrals, including to Closing the Gap programs and Indigenous-specific services.

Key Health Disparities

Health Condition Indigenous:Non-Indigenous Disparity GP Action
Type 2 diabetes 3.5× higher prevalence; earlier onset; higher complication rates Annual HbA1c, renal function, diabetic retinal screening, foot checks (MBS 715); Close the Gap PBS co-payment for medications
Chronic kidney disease 2–3× higher rate of dialysis-requiring ESKD Annual eGFR + ACR for all at-risk patients; early nephrology referral
Rheumatic heart disease (RHD) Rare in non-Indigenous Australians; disproportionately affects Indigenous children in remote NT, QLD, WA Sore throat and skin sore management in children; secondary prophylaxis with benzathine penicillin G (register-based recall — RHDAustralia); echocardiography referral
Trachoma Australia is the only developed country with endemic trachoma; predominantly in remote NT Screening with MBS 715; SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement)
Mental health and suicide Psychological distress 2.5× higher; suicide rate 2× higher (particularly young males) K5/K10 screening; GP Mental Health Treatment Plan (MBS 2710, 2712); referral to culturally safe services (e.g., VACCHO, Thirrili for suicide bereavement support); 13YARN crisis line
Ear disease (otitis media) Chronic suppurative otitis media rates up to 10× higher in remote communities Otoscopy at every paediatric consultation; audiology referral; ENT referral for chronic perforation or cholesteatoma
Closing the Gap PBS Co-Payment: Aboriginal and Torres Strait Islander Australians who have or are at risk of a chronic disease can access PBS medicines at a reduced co-payment rate (equivalent to the concessional rate) regardless of concession card status. The GP must indicate "CTG" on the prescription and register the patient with Services Australia. This significantly reduces medication cost barriers.

📚 References

  1. 1. Kurtz SM, Silverman JD, Draper J. Teaching and Learning Communication Skills in Medicine. 2nd ed. Oxford: Radcliffe Publishing; 2005.
  2. 2. Pendleton D, Schofield T, Tate P, Havelock P. The Consultation: An Approach to Learning and Teaching. Oxford: Oxford University Press; 1984.
  3. 3. Stewart M, Brown JB, Weston WW, McWhinney IR, McWilliam CL, Freeman TR. Patient-Centred Medicine: Transforming the Clinical Method. 3rd ed. London: CRC Press; 2014.
  4. 4. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129–136.
  5. 5. Balint M. The Doctor, His Patient and the Illness. London: Pitman Medical; 1957.
  6. 6. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. 3rd ed. New York: Guilford Press; 2013.
  7. 7. Stuart MR, Lieberman JA. The Fifteen Minute Hour: Efficient and Effective Patient-Centred Consultation Skills. 6th ed. London: CRC Press; 2018.
  8. 8. Beckman HB, Frankel RM. The effect of physician behavior on the collection of data. Ann Intern Med. 1984;101(5):692–696.
  9. 9. Hampton JR, Harrison MJ, Mitchell JR, Prichard JS, Seymour C. Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. BMJ. 1975;2(5969):486–489.
  10. 10. Royal Australian College of General Practitioners (RACGP). Curriculum for Australian General Practice 2022. Melbourne: RACGP; 2022.
  11. 11. Australian Institute of Health and Welfare (AIHW). Australia's Health 2022. Canberra: AIHW; 2022.
  12. 12. Britt H, Miller GC, Henderson J, et al. General Practice Activity in Australia 2015–16. Sydney: Sydney University Press; 2016. (BEACH — Bettering the Evaluation and Care of Health.)
  13. 13. Brodaty H, Pond D, Kemp NM, et al. The GPCOG: a new screening test for dementia designed for general practice. Neurology. 2002;58(4):551–557.
  14. 14. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699.
  15. 15. Australian Bureau of Statistics (ABS). Census of Population and Housing, 2021. Canberra: ABS; 2022.
  16. 16. Services Australia. Medicare Benefits Schedule (MBS) Online. Canberra: Australian Government. Available at: www.mbsonline.gov.au.
  17. 17. National Health and Medical Research Council (NHMRC). Shared Decision Making in Australia. Canberra: NHMRC; 2023.
  18. 18. RHDAustralia (Rheumatic Heart Disease Australia). ARF/RHD Clinical Guidelines. Darwin: Menzies School of Health Research; 2020.
for PBS-listed medicines at participating pharmacies.
Cultural safety
Engagement with Aboriginal Community Controlled Health Organisations (ACCHOs) is essential. Cultural safety training for non-Indigenous clinicians, use of Aboriginal Health Workers and Liaison Officers, and incorporation of traditional healing practices alongside Western medicine improve treatment adherence and outcomes. Avoidance of eye contact, respect for gender-sensitive examination practices, and understanding of sorry business protocols are critical elements of culturally safe care.
Medication adherence
Complex DMARD regimens with frequent monitoring requirements present adherence challenges. Long-acting depot injections (e.g., methotrexate SC) may improve adherence compared to oral regimens. Community pharmacy partnerships through the Indigenous Pharmacy Programmes improve medication management.
Specific conditions
Rheumatic heart disease (RHD) requires secondary prophylaxis with benzathine penicillin G (BPG) 1.2 MU IM every 3–4 weeks for a minimum of 10 years or until age 21 (whichever is longer). RHD registers (e.g., NT RHD Register) facilitate recall and follow-up. The Australian RHD Endgame Strategy targets elimination by 2031.
Referral pathways
Referral through ACCHOs and Aboriginal Hospital Liaison Officers (AHLOs) improves engagement. The Specialist Outreach Assistance Programme provides funded specialist visits to remote communities. NT, WA, and QLD have specific rheumatology outreach programmes targeting Indigenous communities.

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Autoimmune disease in Australia. Cat. no. PHE 312. Canberra: AIHW; 2023.
  2. 2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939.
  3. 3. Fanouriakis A, Kostopoulou M, Alber K, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
  4. 4. Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2021;73(11):1583–1599.
  5. 5. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
  6. 6. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health; 2024. Available from: immunisationhandbook.health.gov.au.
  7. 7. Rheumatic Heart Disease Australia (RHDAustralia). The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. Darwin: Menzies School of Health Research; 2020.
  8. 8. Pharmaceutical Benefits Scheme (PBS). PBS Schedule. Australian Government Department of Health. Available from: pbs.gov.au. Accessed 2024.
  9. 9. Agarwal S, Cunnington J, Nossent J. Autoimmune disease in Indigenous Australians: a systematic review. Int J Rheum Dis. 2021;24(12):1487–1498.
  10. 10. Pisetsky DS. Antinuclear antibody testing — misunderstood or misused? Clin Immunol. 2023;255:109717.
  11. 11. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
  12. 12. Ledingham J, Deighton C; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44(2):155–158.
  13. 13. National Health and Medical Research Council (NHMRC). National statement on ethical conduct in human research. Canberra: NHMRC; 2023 (updated).
for PBS-listed medicines at participating pharmacies.
Cultural safety
Engagement with Aboriginal Community Controlled Health Organisations (ACCHOs) is essential. Cultural safety training for non-Indigenous clinicians, use of Aboriginal Health Workers and Liaison Officers, and incorporation of traditional healing practices alongside Western medicine improve treatment adherence and outcomes. Avoidance of eye contact, respect for gender-sensitive examination practices, and understanding of sorry business protocols are critical elements of culturally safe care.
Medication adherence
Complex DMARD regimens with frequent monitoring requirements present adherence challenges. Long-acting depot injections (e.g., methotrexate SC) may improve adherence compared to oral regimens. Community pharmacy partnerships through the Indigenous Pharmacy Programmes improve medication management.
Specific conditions
Rheumatic heart disease (RHD) requires secondary prophylaxis with benzathine penicillin G (BPG) 1.2 MU IM every 3–4 weeks for a minimum of 10 years or until age 21 (whichever is longer). RHD registers (e.g., NT RHD Register) facilitate recall and follow-up. The Australian RHD Endgame Strategy targets elimination by 2031.
Referral pathways
Referral through ACCHOs and Aboriginal Hospital Liaison Officers (AHLOs) improves engagement. The Specialist Outreach Assistance Programme provides funded specialist visits to remote communities. NT, WA, and QLD have specific rheumatology outreach programmes targeting Indigenous communities.

📚 References

  1. 1. Australian Institute of Health and Welfare (AIHW). Autoimmune disease in Australia. Cat. no. PHE 312. Canberra: AIHW; 2023.
  2. 2. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2021;73(7):924–939.
  3. 3. Fanouriakis A, Kostopoulou M, Alber K, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78(6):736–745.
  4. 4. Chung SA, Langford CA, Maz M, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. 2021;73(11):1583–1599.
  5. 5. Smolen JS, Landewé RBM, Bijlsma JWJ, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
  6. 6. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health; 2024. Available from: immunisationhandbook.health.gov.au.
  7. 7. Rheumatic Heart Disease Australia (RHDAustralia). The 2020 Australian guideline for prevention, diagnosis, and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. Darwin: Menzies School of Health Research; 2020.
  8. 8. Pharmaceutical Benefits Scheme (PBS). PBS Schedule. Australian Government Department of Health. Available from: pbs.gov.au. Accessed 2024.
  9. 9. Agarwal S, Cunnington J, Nossent J. Autoimmune disease in Indigenous Australians: a systematic review. Int J Rheum Dis. 2021;24(12):1487–1498.
  10. 10. Pisetsky DS. Antinuclear antibody testing — misunderstood or misused? Clin Immunol. 2023;255:109717.
  11. 11. Bertsias GK, Tektonidou M, Amoura Z, et al. Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 2012;71(11):1771–1782.
  12. 12. Ledingham J, Deighton C; British Society for Rheumatology Standards, Audit and Guidelines Working Group. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis. Rheumatology. 2005;44(2):155–158.
  13. 13. National Health and Medical Research Council (NHMRC). National statement on ethical conduct in human research. Canberra: NHMRC; 2023 (updated).